Oliver, Lisa
Landais, Yuna
Gratas, Catherine
Cartron, Pierre-François
Paris, François
Heymann, Dominique
Vallette, François M. https://orcid.org/0000-0002-3296-8572
Serandour, Aurelien
Article History
Received: 11 June 2024
Accepted: 28 October 2024
First Online: 14 November 2024
Declarations
:
: The bio-collection used for this analysis is the Glioblastoma collection belonging to the approved project, “pediatric research program of the University Hospital of Nantes, France (Ref. MESR DC-2014–2206)”, having obtained an institutional approval from committee patients protection board, “CPP Ouest IV, approval number “Dossier 06/15”, date of approval 08/04/2015. The patients or their guardians/legally authorized representatives/next of kin provided written informed consent for participation in the use of samples. After informed consent, tumor samples classified as GBM, based on the World Health Organization criteria, were obtained from patients undergoing surgical intervention at the Department of Neurosurgery at “Centre Hospitalier Universitaire de Nantes” and the “Tumorothèque IRCNA”.
: The authors declare that artificial intelligence is not used in this study.
: The authors declare that they have no competing of interest.